Stock MATD3 HOSPITAL MATER DEI S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Hospital Mater Dei S.A.

Equities

MATD3

BRMATDACNOR4

Healthcare Facilities & Services

Market Closed - Sao Paulo
Other stock markets
 01:37:00 29/06/2024 am IST 		5-day change 1st Jan Change
4.55 BRL -17.38% Intraday chart for Hospital Mater Dei S.A. -2.36% -45.51%
08/05 Hospital Mater Dei S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05/04 Hospital Mater Dei S.A. announces an Equity Buyback for 9,613,168 shares, representing 2.51% of its issued share capital. CI

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 5,161 2,757 3,190 1,738 - -
Enterprise Value (EV) 1 5,574 4,359 4,969 3,408 3,202 3,037
P/E ratio 30.7 x 28.8 x 27.8 x 8.1 x 5.91 x 5.36 x
Yield 0.67% - - 2.67% 3.19% 4.57%
Capitalization / Revenue 5.04 x 1.56 x 1.46 x 0.73 x 0.66 x 0.6 x
EV / Revenue 5.44 x 2.47 x 2.27 x 1.43 x 1.22 x 1.05 x
EV / EBITDA 18.1 x 10.2 x 9.45 x 6 x 4.89 x 4.11 x
EV / FCF -30.5 x -16.7 x -195 x 37 x 14.1 x 11.8 x
FCF Yield -3.28% -6% -0.51% 2.7% 7.09% 8.49%
Price to Book - 1.75 x - 1.03 x 0.92 x -
Nbr of stocks (in thousands) 3,82,330 3,82,330 3,82,043 3,82,043 - -
Reference price 2 13.50 7.210 8.350 4.550 4.550 4.550
Announcement Date 29/03/22 15/03/23 28/03/24 - - -
1BRL in Million2BRL
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 717.9 1,024 1,763 2,188 2,387 2,615 2,885
EBITDA 1 - 308.4 428 525.6 567.8 654.5 739.6
EBIT 1 - 242.3 337.9 423.6 466.5 551.5 636.5
Operating Margin - 23.65% 19.16% 19.36% 19.55% 21.09% 22.06%
Earnings before Tax (EBT) 1 - - 185.8 208.8 302.4 406.8 456.1
Net income 1 - 146.8 103.5 119.7 184.5 250.6 281.2
Net margin - 14.34% 5.87% 5.47% 7.73% 9.58% 9.75%
EPS 2 0.2200 0.4400 0.2500 0.3000 0.5620 0.7705 0.8489
Free Cash Flow 1 - -182.6 -261.7 -25.54 92 227 257.7
FCF margin - -17.83% -14.84% -1.17% 3.85% 8.68% 8.93%
FCF Conversion (EBITDA) - - - - 16.2% 34.68% 34.84%
FCF Conversion (Net income) - - - - 49.86% 90.57% 91.62%
Dividend per Share 2 - 0.0900 - - 0.1213 0.1451 0.2079
Announcement Date 11/02/21 29/03/22 15/03/23 28/03/24 - - -
1BRL in Million2BRL
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 288.2 342.7 466.2 473.9 512.1 524.1 554.2 568.2 541.2 582.8 - - -
EBITDA 78.6 89.93 120.4 119.8 121.8 131.9 147 134.3 112.5 139.5 - - -
EBIT 45.31 64.89 87.08 94.13 91.81 106.2 122.1 108.8 86.5 112.1 - - -
Operating Margin 15.72% 18.93% 18.68% 19.86% 17.93% 20.27% 22.04% 19.14% 15.98% 19.24% - - -
Earnings before Tax (EBT) - - - - - - - - - - - - -
Net income - 26.58 29.22 33.72 13.97 27.21 38.09 28.55 25.8 42.18 - - -
Net margin - 7.76% 6.27% 7.12% 2.73% 5.19% 6.87% 5.02% 4.77% 7.24% - - -
EPS 1 -0.0600 0.0600 0.0800 0.0700 0.0300 0.0700 0.0900 0.0700 0.0700 0.1000 0.1250 0.1341 0.1274
Dividend per Share - - - - - - - - - - - - -
Announcement Date 29/03/22 12/05/22 10/08/22 09/11/22 15/03/23 15/05/23 10/08/23 13/11/23 28/03/24 07/05/24 - - -
1BRL
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - 412 1,602 1,779 1,670 1,464 1,298
Net Cash position 1 - - - - - - -
Leverage (Debt/EBITDA) - 1.336 x 3.744 x 3.385 x 2.941 x 2.237 x 1.755 x
Free Cash Flow 1 - -183 -262 -25.5 92 227 258
ROE (net income / shareholders' equity) - 17.2% 6.36% 7.31% 11.5% 13.4% 14.3%
ROA (Net income/ Total Assets) - 6.2% 2.29% 2.37% 3.35% 5.04% 5.76%
Assets 1 - 2,368 4,512 5,052 5,511 4,978 4,885
Book Value Per Share 2 - - 4.110 - 4.430 4.970 -
Cash Flow per Share - - -0.1500 - - - -
Capex 1 - 114 200 183 231 141 161
Capex / Sales - 11.12% 11.34% 8.35% 9.67% 5.4% 5.56%
Announcement Date 11/02/21 29/03/22 15/03/23 28/03/24 - - -
1BRL in Million2BRL
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Hospital Mater Dei S.A.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
4.55 BRL
Average target price
8.786 BRL
Spread / Average Target
+93.09%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Hospitals, Clinics & Primary Care Services

1st Jan change Capi.
HOSPITAL MATER DEI S.A. Stock Hospital Mater Dei S.A.
-45.51% 31Cr
AIER EYE HOSPITAL GROUP CO., LTD. Stock Aier Eye Hospital Group Co., Ltd.
-34.77% 1.32TCr
IHH HEALTHCARE Stock IHH Healthcare
+4.48% 1.18TCr
BANGKOK DUSIT MEDICAL SERVICES Stock Bangkok Dusit Medical Services
-3.60% 1.16TCr
APOLLO HOSPITALS ENTERPRISE LIMITED Stock Apollo Hospitals Enterprise Limited
+8.44% 1.07TCr
ENCOMPASS HEALTH CORPORATION Stock Encompass Health Corporation
+28.58% 863.85Cr
RAMSAY HEALTH CARE LIMITED Stock Ramsay Health Care Limited
-9.79% 724.36Cr
THE ENSIGN GROUP, INC. Stock The Ensign Group, Inc.
+10.23% 698.42Cr
MOUWASAT MEDICAL SERVICES COMPANY Stock Mouwasat Medical Services Company
+8.41% 646.11Cr
CONCORD HEALTHCARE GROUP CO., LTD. Stock Concord Healthcare Group Co., Ltd.
0.00% 499.07Cr
Hospitals, Clinics & Primary Care Services
  1. Stock Market
  2. Equities
  3. MATD3 Stock
  4. Financials Hospital Mater Dei S.A.